Margaret Harkins (Meg)

Margaret (Meg) Harkins has over 30 years of work experience. Margaret (Meg) is currently working as the Director, Global Pharmacovigilance Safety Surveillance Scientist at Melinta Therapeutics. Prior to that, they served as a Project Manager, Pharmacovigilance at United Biosource LLC from 2019 to 2021. From 2017 to 2019, they worked as a Team Manager-Global Case Processing, Pharmacovigilance at UnitedBiosource Corporation, overseeing multiple client projects and leading a team of 7 direct reports. Between 2013 and 2017, Meg worked as a Senior Safety Scientist at United BioSource Corporation.

Before transitioning to the pharmaceutical industry, Meg gained experience in adverse event coordination and safety reporting. Margaret (Meg) worked as an Adverse Event Coordinator III at Merck (via Joule Scientific Staffing Solutions) from 2012 to 2013, ensuring accurate and timely exchange of adverse event information. From 2011 to 2012, they served as the Product Safety Surveillance and Reporting (PSSR) Manager, Consumer Healthcare at Pfizer, where they reviewed and completed adverse drug experience reports and supported the collection and assessment of individual case safety reports.

Meg's experience also includes positions at Wyeth, where they served as a Global Pharmacovigilance Product Specialist from 2010 to 2011, independently assessing and processing individual case summary reports and preparing periodic safety reports. Prior to that, they worked as an Adverse Event Specialist II from 2005 to 2009, managing expedited and non-serious individual case summary reports and preparing periodic safety reports for female healthcare products.

Meg's career began at The Children's Hospital of Philadelphia, where they held various roles from 1988 to 2005. Margaret (Meg) worked as a Research Coordinator, coordinating national studies and handling responsibilities such as budget development and data collection. Margaret (Meg) also worked as a Staff Nurse in the Intensive Care Unit and the Telemetry Unit, providing critical nursing care to patients with cardiovascular disease and performing hemodynamic monitoring and ventilator management.

Overall, Meg Harkins has a diverse background in pharmacovigilance, safety surveillance, adverse event coordination, and nursing, with a strong emphasis on compliance, regulatory reporting, and team management.

From 1980 to 1988, Margaret Harkins attended Villanova University, where they pursued a Bachelor of Science (BS) degree in Biology and Nursing.